Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Microbix Biosystems Inc. MBXBF

Set alert

Price alert · MBXBF

All alert types
0.22 USD 0.00 0.00%

At close · Oct 30

0.22 Day range 0.22
0.154 52-week range 0.232
YTD
+26.44%
1 year
+22.22%
Open
0.22
Prev close
0.22
Mkt cap
30.13M
Vol
2.50K
Avg vol
1.85K
EPS
-0.03
P/E
0.00
More statistics
Low
0.22
High
0.22

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for MBXBF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

1.65 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 4

Valuation

P/E -16.2×
FY 2016: 25.7×FY 2017: -7.7×FY 2018: -2.6×FY 2019: 750×FY 2020: -4.2×FY 2021: 43.7×FY 2022: 39.1×FY 2023: -1044×FY 2024: 13.3×FY 2025: -16.2×
FY 2016 5y median 13.3× FY 2025
P/S 2.0×
FY 2016: 2.1×FY 2017: 2.9×FY 2018: 1.8×FY 2019: 1.6×FY 2020: 2.5×FY 2021: 3.8×FY 2022: 3.7×FY 2023: 2.6×FY 2024: 1.8×FY 2025: 2.0×
FY 2016 5y median 2.6× FY 2025
P/B 1.3×
FY 2016: 1.3×FY 2017: 1.9×FY 2018: 2.2×FY 2019: 2.1×FY 2020: 4.0×FY 2021: 3.8×FY 2022: 2.8×FY 2023: 1.8×FY 2024: 1.7×FY 2025: 1.3×
FY 2016 5y median 1.8× FY 2025
P/FCF -41.5×
FY 2016: -26.9×FY 2017: -85.1×FY 2018: -12.9×FY 2019: -46.4×FY 2020: -32.8×FY 2021: 88.7×FY 2022: 48.5×FY 2023: -20.5×FY 2024: 19.2×FY 2025: -41.5×
FY 2016 5y median 19.2× FY 2025
EV/EBITDA 159×
FY 2016: 21.5×FY 2017: -13.0×FY 2018: -4.1×FY 2019: 17.1×FY 2020: -11.2×FY 2021: 12.2×FY 2022: 18.7×FY 2023: 19.5×FY 2024: 6.5×FY 2025: 159×
FY 2016 5y median 18.7× FY 2025
EV/Sales 1.7×
FY 2016: 2.8×FY 2017: 3.6×FY 2018: 2.3×FY 2019: 2.1×FY 2020: 3.1×FY 2021: 3.7×FY 2022: 3.3×FY 2023: 2.3×FY 2024: 1.6×FY 2025: 1.7×
FY 2016 5y median 2.3× FY 2025
FCF Yield -2.4%
FY 2016: -3.7%FY 2017: -1.2%FY 2018: -7.8%FY 2019: -2.2%FY 2020: -3.0%FY 2021: 1.1%FY 2022: 2.1%FY 2023: -4.9%FY 2024: 5.2%FY 2025: -2.4%
FY 2016 5y median 1.1% FY 2025

Profitability

Gross Margin 53.0%
FY 2016: 52.3%FY 2017: 47.2%FY 2018: 42.9%FY 2019: 48.8%FY 2020: 44.3%FY 2021: 59.4%FY 2022: 58.3%FY 2023: 45.3%FY 2024: 60.6%FY 2025: 53.0%
FY 2016 5y median 58.3% FY 2025
Operating Margin -8.5%
FY 2016: 1.6%FY 2017: -14.7%FY 2018: -5.9%FY 2019: 8.3%FY 2020: -5.0%FY 2021: 26.0%FY 2022: 14.1%FY 2023: -16.6%FY 2024: 15.4%FY 2025: -8.5%
FY 2016 5y median 14.1% FY 2025
Net Margin -12.1%
FY 2016: 7.9%FY 2017: -37.1%FY 2018: -68.9%FY 2019: 0.2%FY 2020: -59.2%FY 2021: 8.8%FY 2022: 9.4%FY 2023: -0.2%FY 2024: 13.9%FY 2025: -12.1%
FY 2016 5y median 8.8% FY 2025
ROE -8.1%
FY 2016: 4.9%FY 2017: -24.9%FY 2018: -83.3%FY 2019: 0.3%FY 2020: -94.1%FY 2021: 8.8%FY 2022: 7.2%FY 2023: -0.2%FY 2024: 12.4%FY 2025: -8.1%
FY 2016 5y median 7.2% FY 2025
ROIC -4.4%
FY 2016: 0.7%FY 2017: -6.0%FY 2018: -4.5%FY 2019: 4.6%FY 2020: -4.1%FY 2021: 18.4%FY 2022: 8.4%FY 2023: -8.7%FY 2024: 10.7%FY 2025: -4.4%
FY 2016 5y median 8.4% FY 2025
ROA -6.0%
FY 2016: 3.0%FY 2017: -14.3%FY 2018: -44.6%FY 2019: 0.2%FY 2020: -39.9%FY 2021: 5.7%FY 2022: 5.4%FY 2023: -0.1%FY 2024: 9.2%FY 2025: -6.0%
FY 2016 5y median 5.4% FY 2025

Growth (YoY)

Revenue -26.7%
FY 2016: 7.2%FY 2017: 7.0%FY 2018: 22.8%FY 2019: 7.2%FY 2020: -21.5%FY 2021: 76.7%FY 2022: 2.6%FY 2023: -13.4%FY 2024: 53.8%FY 2025: -26.7%
FY 2016 FY 2025
Operating Income -140.4%
FY 2016: -57.5%FY 2017: -1110.4%FY 2018: 50.5%FY 2019: 249.4%FY 2020: -147.3%FY 2021: 1022.0%FY 2022: -44.3%FY 2023: -201.6%FY 2024: 242.7%FY 2025: -140.4%
FY 2016 FY 2025
EPS (diluted) -163.3%
FY 2016: 28.6%FY 2017: -595.6%FY 2018: -100.9%FY 2019: 100.3%FY 2020: -19900.0%FY 2021: 119.4%FY 2022: 9.6%FY 2023: -102.4%FY 2024: 8633.3%FY 2025: -163.3%
FY 2016 FY 2025
Free Cash Flow -136.0%
FY 2016: 82.9%FY 2017: 52.8%FY 2018: -410.6%FY 2019: 73.2%FY 2020: -71.2%FY 2021: 199.9%FY 2022: 79.0%FY 2023: -246.6%FY 2024: 215.6%FY 2025: -136.0%
FY 2016 FY 2025

Financial Health

Current Ratio 8.5×
FY 2016: 1.1×FY 2017: 0.9×FY 2018: 1.5×FY 2019: 1.4×FY 2020: 1.6×FY 2021: 3.7×FY 2022: 8.5×FY 2023: 5.1×FY 2024: 7.1×FY 2025: 8.5×
FY 2016 5y median 7.1× FY 2025
Quick Ratio 5.2×
FY 2016: 0.4×FY 2017: 0.3×FY 2018: 0.4×FY 2019: 0.4×FY 2020: 0.5×FY 2021: 2.8×FY 2022: 6.5×FY 2023: 3.8×FY 2024: 5.2×FY 2025: 5.2×
FY 2016 5y median 5.2× FY 2025
Debt / Equity 0.3×
FY 2016: 0.5×FY 2017: 0.5×FY 2018: 0.6×FY 2019: 0.7×FY 2020: 0.9×FY 2021: 0.4×FY 2022: 0.2×FY 2023: 0.3×FY 2024: 0.2×FY 2025: 0.3×
FY 2016 5y median 0.3× FY 2025
Net Debt / EBITDA -19.9×
FY 2016: 5.9×FY 2017: -2.6×FY 2018: -0.9×FY 2019: 4.1×FY 2020: -2.1×FY 2021: -0.4×FY 2022: -2.3×FY 2023: -2.5×FY 2024: -1.1×FY 2025: -19.9×
FY 2016 5y median -2.3× FY 2025
Interest Coverage -1.7×
FY 2016: 0.2×FY 2017: -1.6×FY 2018: -0.9×FY 2019: 1.0×FY 2020: -0.5×FY 2021: 3.0×FY 2022: 3.3×FY 2023: -3.3×FY 2024: 4.2×FY 2025: -1.7×
FY 2016 5y median 3.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-09-30